EXPORT LIST RSS ?
Sharonb's bookmarks matching tag prognostics
 
Number of articles per page:
10 | 25 | 50 | 100
 
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.
Lluís Colomo et al.
Blood 101 (1), 78-84 (01 Jan 2003)
info:pmid/12393466 | info:doi/10.1182/blood-2002-04-1286
Posted by Sharonb to prognostics Bcl2 GC DLBCL on Fri May 30 2008 at 14:04 UTC | info | related
 
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.
Daphne de Jong et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 25 (7), 805-12 (01 Mar 2007)
info:pmid/17327602 | info:doi/10.1200/JCO.2006.09.4490
Posted by Sharonb and 1 other to prognostics Immunohistochemistry tissue Array DLBCL on Fri May 30 2008 at 13:54 UTC | info | related
 
Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP
Minna Taskinen, Marja-Liisa Karjalainen-Lindsberg, and Sirpa Leppa
Blood 111 (9), (01 May 2008)
info:pmid/18309035 | info:doi/10.1182/blood-2007-11-125823
Posted by Sharonb to prognostics TAMs follicular microenvironment on Mon Apr 28 2008 at 11:42 UTC | info | related
 
Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab.
Lynette Ngo et al.
Leukemia & lymphoma 49 (3), 462-9 (Mar 2008)
info:pmid/18297522 | info:doi/10.1080/10428190701809156
Posted by Sharonb to prognostics CHOP-R DLBCL on Mon Mar 03 2008 at 18:11 UTC | info | related
 
Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis.
Anuradha Kanungo et al.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 19 (1), 25-33 (Jan 2006)
info:pmid/16258503 | info:doi/10.1038/modpathol.3800500
Posted by Sharonb to t(14;18) prognostics cMyc on Mon Feb 18 2008 at 17:28 UTC | info | related
 
Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.
Jane N Winter et al.
Blood 107 (11), 4207-13 (01 Jun 2006)
info:pmid/16449523 | info:doi/10.1182/blood-2005-10-4222
Posted by Sharonb to prognostics CHOP-R BCL6 on Mon Feb 18 2008 at 17:25 UTC | info | related
 
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
Yasodha Natkunam et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26 (3), JCO.2007.13.0690v1-454 (17 Dec 2007)
info:pmid/18086797 | info:doi/10.1200/JCO.2007.13.0690
Posted by Sharonb and 1 other to prognostics CHOP-R LMO2 on Mon Feb 18 2008 at 17:01 UTC | info | related
 
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
Laurie H Sehn et al.
Blood 109 (5), 1857-61 (01 Mar 2007)
info:pmid/17105812 | info:doi/10.1182/blood-2006-08-038257
Posted by Sharonb and 2 others to prognostics IPI CHOP-R on Fri Feb 15 2008 at 17:01 UTC | info | related
 
Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.
Heidi Nyman et al.
Blood 109 (11), 4930-5 (01 Jun 2007)
info:pmid/17299093 | info:doi/10.1182/blood-2006-09-047068
Posted by Sharonb to prognostics CHOP-R GC on Fri Feb 15 2008 at 16:58 UTC | info | related
 
Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma.
Latha Shivakumar and James O Armitage
Clinical lymphoma & myeloma 6 (6), 455-7 (May 2006)
info:pmid/16796775
Posted by Sharonb to prognostics Bcl2 on Fri Feb 15 2008 at 16:54 UTC | info | related

<< Prev 0      Showing entries 1 to 10 of 14 total      Next 4 >>